CP
Christoph Preschern
Managing Director And Chief Strategy Officer at Ranorex
View Christoph's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Oct 2009 - Present · 15 years and 2 months
Managing Director And Chief Strategy Officer
Nov 2016 - Present · 8 years and 1 months
General Manager And Chief Creative Officer
Jul 2016 - Present · 8 years and 5 months
Head Of Sales And Chief Creative Officer
Oct 2009 - Jun 2016 · 6 years and 8 months
Company Details
51-200 Employees
Ranorex offers innovative test automation solutions that help more than 10,000 users worldwide deliver high-quality desktop, web and mobile applications. Our flagship product, Ranorex Studio, provides all-in-one test automation across devices, platforms, and technologies. Ranorex Studio helps teams of all sizes, skills and methodologies accomplish their test automation goals. Automation experts can use the powerful test automation API, while its tools for codeless test creation empower testers to grow their automation skills. All members of cross-functional teams can collaborate on solutions by sharing reusable test automation modules. Ranorex products are supported by a team of professionals dedicated to your success.
Year Founded
2007
Social Media
LinkedinFacebookTwitter
Industry
Software Development, Electronic data processing (EDP) services, Information technology (IT) and Internet, IT, Internet, R&D, Information technology (IT) hosting services, Information technology (IT) engineering
HQ Location
10801 N Mo Pac Expy Building 1, Suite 100 Austin, Texas 78759, US
Keywords
Software Test AutomationAutomated TestingMobile App TestingWeb Testing ToolsAutomated Gui TestingCross Platform & Device TestingCross Browser TestingData Driven TestsKeyword Driven TestsRegression Testing
Discover More About Cleveland Clinic

Find verified contacts of Christoph Preschern in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.